Lv32
254 积分 2024-04-26 加入
CAR T-cell Therapy in SLE: A Systematic Review
2小时前
已完结
Antigen experience history directs distinct functional states of CD8+ CAR T cells during the antileukemia response
4天前
已完结
The race to reset autoimmune diseases
6天前
已完结
Anti–CD19 CAR T Cells in Refractory Immune Thrombocytopenia of SLE
7天前
已完结
Autoimmune haemolytic anaemias
7天前
已完结
Cardiolipin-mimic lipid nanoparticles without antibody modification delivered senolytic in vivo CAR-T therapy for inflamm-aging
18天前
已完结
Teclistamab in relapsed systemic sclerosis after autologous haematopoietic stem cell transplantation
22天前
已完结
BCMA-Targeted T-Cell–Engager Therapy for Autoimmune Disease
22天前
已完结
Comparison of the safety profiles of CD19-targeting CAR T-cell therapy in patients with SLE and B-cell lymphoma
1个月前
已完结
FDA Experience on CAR T Cell Pharmacokinetics/Pharmacodynamics and Model‐Based Assessments
2个月前
已完结
皖公网安备34019202002308
